Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › 5,6,7-trihydroxyheptanoic acid and analogs for the treatment of ocular diseases and diseases associated with hyperproliferative and angiogenic responses

5,6,7-trihydroxyheptanoic acid and analogs for the treatment of ocular diseases and diseases associated with hyperproliferative and angiogenic responses

US Patent 7879905 · Granted Feb 1, 2011

Estimated economic value: $36,923,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Fixation members, assemblies, and related systems and methods2023
Ocular formulations for drug-delivery to the posterior segment of the eye2019
Ocular formulations for drug-delivery and protection of the anterior segment of 2019
Ocular formulations for drug-delivery to the posterior segment of the eye2018
NPR-B agonists2018
Methods of treating ophthalmic diseases using NPR-B agonists2017
Ocular formulations for drug-delivery and protection of the anterior segment of 2017
RNAi-mediated inhibition of phosphodiesterase type 4 for treatment of CAMP-relat2017
NPR-B agonists2017
RNAi-mediated inhibition of histamine receptor H1-related conditions2017
Ocular formulations for drug-delivery and protection of the anterior segment of 2017
High concentration olopatadine ophthalmic composition2017